225 related articles for article (PubMed ID: 11036917)
1. Short-acting beta2-agonists.
Lee T; Dennis S
Lancet; 2000 Sep; 356(9233):940-1. PubMed ID: 11036917
[No Abstract] [Full Text] [Related]
2. Long-acting beta 2-agonists: the new symptom controllers for asthma.
Jenkins CR
Med J Aust; 1999 Sep; 171(5):255-8. PubMed ID: 10495758
[No Abstract] [Full Text] [Related]
3. [Long acting beta-2 agonists. Discussion of their use in asthma].
Aumiller J
MMW Fortschr Med; 2009 Apr; 151(15):14. PubMed ID: 19728671
[No Abstract] [Full Text] [Related]
4. [Use of glucocorticosteroids in asthmatic conditions (review)].
Rebrov AP; Karoli NA
Ter Arkh; 2001; 73(3):63-7. PubMed ID: 11417187
[No Abstract] [Full Text] [Related]
5. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
Sin DD; Man SF
Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
[TBL] [Abstract][Full Text] [Related]
6. Long-acting beta agonists--prescribe with care.
Crane J
N Z Med J; 2006 Jul; 119(1237):U2064. PubMed ID: 16862206
[No Abstract] [Full Text] [Related]
7. [Medical measures in status asthmaticus. Progressive airway obstruction can be therapeutically controlled today--bronchodilators].
Höltmann B
Fortschr Med; 1988 Mar; 106(9):18-20. PubMed ID: 3371832
[No Abstract] [Full Text] [Related]
8. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
9. Long-acting beta-agonists and exercise.
Weinberger M
J Allergy Clin Immunol; 2008 Aug; 122(2):251-3. PubMed ID: 18582922
[No Abstract] [Full Text] [Related]
10. [Effects of a beta-adrenergic stimulant: Salbutamol, on spontaneous or induced bronchial obstruction in asthma].
Orehek J; Gayrard P; Charpin J
Mars Med; 1972; 109(11):713-7. PubMed ID: 4145413
[No Abstract] [Full Text] [Related]
11. Long-acting beta(2) agonists as potential option in the treatment of acute exacerbations of COPD.
Cazzola M; Matera MG
Pulm Pharmacol Ther; 2003; 16(4):197-201. PubMed ID: 12850121
[No Abstract] [Full Text] [Related]
12. [symbol: see text] Seretide and [symbol: see text] Symbicort in asthma management.
Drug Ther Bull; 2002 Aug; 40(8):62-4. PubMed ID: 12216339
[TBL] [Abstract][Full Text] [Related]
13. Meeting the obligation to balance bioethics and clinical trial design in asthma.
Bleecker ER; Nelson HS; Kraft M; Corren J; Meyers DA; Yancey SW; Anderson WH; Emmett AH; Ortega HA
Am J Respir Crit Care Med; 2010 Apr; 181(7):648-50. PubMed ID: 20335380
[No Abstract] [Full Text] [Related]
14. [Long-acting beta2-agonist bronchodilators safety for asthma treatment].
Giubergia V
Arch Argent Pediatr; 2009 Aug; 107(4):291-3. PubMed ID: 19753432
[No Abstract] [Full Text] [Related]
15. Treatment of severe asthma.
Franklin W
N Engl J Med; 1974 Jun; 290(26):1469-72. PubMed ID: 4151609
[No Abstract] [Full Text] [Related]
16. [Treatment of bronchial asthma in children].
Kaganov SIu; Ioshpa LL
Pediatriia; 1987; (4):64-71. PubMed ID: 2885803
[No Abstract] [Full Text] [Related]
17. Bronchodilators: new drugs and controversies.
Kleerup EC
Curr Opin Pulm Med; 1997 Jan; 3(1):17-22. PubMed ID: 9139768
[TBL] [Abstract][Full Text] [Related]
18. Bronchodilator resuscitation in the emergency department. Part 2 of 2: dosing strategies.
Fink J; Dhand R
Respir Care; 2000 May; 45(5):497-512. PubMed ID: 10813227
[No Abstract] [Full Text] [Related]
19. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
Naedele-Risha R; Dorinsky P; Craig TJ
J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
[TBL] [Abstract][Full Text] [Related]
20. [Drug therapy of airway obstruction. "Completely different for asthma and COPD"].
MMW Fortschr Med; 2008 May; 150(20):14, 16. PubMed ID: 18605635
[No Abstract] [Full Text] [Related]
[Next] [New Search]
